Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma

Lu Wu; Ye-Fa Yang; Jun Liang; Shu-Qun Shen; Nai-Jian Ge; Meng-Chao Wu

doi:10.3748/wjg.v16.i3.398

Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma

World J Gastroenterol. 2010 Jan 21;16(3):398-402. doi: 10.3748/wjg.v16.i3.398.

Authors

Lu Wu¹, Ye-Fa Yang, Jun Liang, Shu-Qun Shen, Nai-Jian Ge, Meng-Chao Wu

Affiliation

¹ The First Department of Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.

Abstract

Cerebral lipiodol embolism (CLE) is an extremely rare complication of transcatheter arterial chemoembolization for hepatocellular carcinoma (HCC). The authors present a case of CLE that occurred after the second hepatic arterial chemoembolization for HCC, and attempt to introduce several plausible mechanisms of CLE, after reporting the clinical and radiological findings and reviewing the medical literature.

Publication types

Case Reports
Review

MeSH terms

Adult
Antineoplastic Agents / administration & dosage
Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic / adverse effects*
Contrast Media / adverse effects
Dose-Response Relationship, Drug
Doxorubicin / administration & dosage
Doxorubicin / analogs & derivatives
Humans
Intracranial Embolism / chemically induced
Intracranial Embolism / etiology*
Intracranial Embolism / pathology
Iodized Oil / adverse effects
Liver Neoplasms / therapy*
Magnetic Resonance Imaging
Male

Substances

Antineoplastic Agents
Contrast Media
Iodized Oil
Doxorubicin
pirarubicin